EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD). The results demonstrated efficacy for a subset of patients suffering from moderate to severe SAD.

Burlington, ON March 11, 2024 – EmpowerPharm Inc. is delighted to announce that the final participant has completed their treatment in the Phase II clinical trial assessing the efficacy of pharmaceutical-grade Cannabidiol (CBD) for Social Anxiety Disorder. The anticipated release of the top-line results are due next month in April.

EmpowerPharm® a clinical stage pharmaceutical company specializing in cannabinoid-based drug development of prescription products. These products target therapeutic indications where patients need safe and efficacious

EmpowerPharm Inc., a clinical-stage pharmaceutical company dedicated to research and clinical advancement, disclosed today that the last participant concluded the treatment and active involvement

This was a virtual panel discussion between leading clinical experts on the state of anxiety in Canada discussing existing and emerging treatments and trends. The

EmpowerPharm Inc was pleased to be invited to participate as a featured guest on the Advancements with Ted Danson series, broadcasted throughout North America.

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been dosed in their Company-sponsored Phase II clinical study.

EmpowerPharm Inc a clinical-stage life sciences company focused on research and clinical development announced today that the first patient has been enrolled in their Company-sponsored Phase II clinical study.

TJ is a commercial leader with over 25 years of experience in both the pharmaceutical and biotech industries. She started her career at larger companies such as Eli Lilly and with her entrepreneurial mindset, gravitated to smaller, Canadian start-up organizations such as Alexion and Mitsubishi Tanabe Pharma.

EmpowerPharm is delighted to announce the appointment of Mr. Chirag Shah who will join our Company as our Vice President Pharmaceutical Development on June 21st. Chirag will lead our development initiatives.